Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1988 Feb;25(2):203–212. doi: 10.1111/j.1365-2125.1988.tb03292.x

(+)-sulpiride antagonises the renal effects of gamma-L-glutamyl-L-dopa in man.

T M MacDonald 1, R F Jeffrey 1, S Freestone 1, M R Lee 1
PMCID: PMC1386475  PMID: 3129007

Abstract

1. gamma-L-glutamyl-L-dopa (gludopa) was given by intravenous infusion to six healthy salt-replete men on two occasions, with and without pretreatment with (+)-sulpiride. 2. Gludopa increased sodium excretion, glomerular filtration rate and effective renal plasma flow whilst decreasing plasma renin activity. 3. (+)-sulpiride had no significant effect on baseline natriuresis, renal haemodynamics or plasma renin activity, but significantly attenuated the rise in sodium excretion, glomerular filtration rate and effective renal plasma flow produced by gludopa. 4. (+)-sulpiride abolished the acute fall in plasma renin activity seen with gludopa. 5. (+)-sulpiride raised serum prolactin concentration but did not affect the ris in urine dopamine excretion rate caused by gludopa. 6. Gludopa exerts its renal effects by stimulating specific dopamine receptors which are principally of the DA1 subtype.

Full text

PDF
203

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANTON A. H., SAYRE D. F. THE DISTRIBUTION OF DOPAMINE AND DOPA IN VARIOUS ANIMALS AND A METHOD FOR THEIR DETERMINATION IN DIVERSE BIOLOGICAL MATERIAL. J Pharmacol Exp Ther. 1964 Sep;145:326–336. [PubMed] [Google Scholar]
  2. Agnoli G. C., Andreone P., Cacciari M., Garutti C., Ikonomu E., Lenzi P. Sulpiride (stereoisomeri, racemico) e dopamina: azioni e interazioni sulla circolazione renale. Boll Soc Ital Biol Sper. 1984 Jan 30;60(1):169–174. [PubMed] [Google Scholar]
  3. Amundsen E., Putter J., Friberger P., Knos M., Larsbraten M., Claeson G. Methods for the determination of glandular kallikrein by means of a chromogenic tripeptide substrate. Adv Exp Med Biol. 1979;120A:83–95. doi: 10.1007/978-1-4757-0926-1_9. [DOI] [PubMed] [Google Scholar]
  4. Baines A. D., Chan W. Production of urine free dopamine from DOPA; a micropuncture study. Life Sci. 1980 Jan 28;26(4):253–259. doi: 10.1016/0024-3205(80)90334-3. [DOI] [PubMed] [Google Scholar]
  5. Bass A. S., Robie N. W. Stereoselectivity of S- and R-sulpiride for pre- and postsynaptic dopamine receptors in the canine kidney. J Pharmacol Exp Ther. 1984 Apr;229(1):67–71. [PubMed] [Google Scholar]
  6. Corvol P., Bisseliches F., Alexandre J. M., Bohuon C., Heurtault J. P., Ménard J., Tcherdakoff P., Vaysse J. C., Milliez P. Poussées hypertensives déclenchées par le sulpride (dogmatil. Ann Med Interne (Paris) 1973 Aug-Sep;124(8):647–649. [PubMed] [Google Scholar]
  7. Dawborn J. K. Application of Heyrovsky's inulin method to automatic analysis. Clin Chim Acta. 1965 Jul;12(1):63–66. doi: 10.1016/0009-8981(65)90109-9. [DOI] [PubMed] [Google Scholar]
  8. Debeljuk L., Daskal H., Rozados R., Guitelman A. Effect of sulpiride on prolactin release by rat pituitaries in vitro. Experientia. 1974 Nov 15;30(11):1355–1356. doi: 10.1007/BF01945226. [DOI] [PubMed] [Google Scholar]
  9. Felder R. A., Blecher M., Calcagno P. L., Jose P. A. Dopamine receptors in the proximal tubule of the rabbit. Am J Physiol. 1984 Sep;247(3 Pt 2):F499–F505. doi: 10.1152/ajprenal.1984.247.3.F499. [DOI] [PubMed] [Google Scholar]
  10. Fraser R., Guest S., Young J. A comparison of double-isotope derivative and radioimmunological estimation of plasma aldosterone concentration in man. Clin Sci Mol Med. 1973 Sep;45(3):411–415. doi: 10.1042/cs0450411. [DOI] [PubMed] [Google Scholar]
  11. Frederickson E. D., Bradley T., Goldberg L. I. Blockade of renal effects of dopamine in the dog by the DA1 antagonist SCH 23390. Am J Physiol. 1985 Aug;249(2 Pt 2):F236–F240. doi: 10.1152/ajprenal.1985.249.2.F236. [DOI] [PubMed] [Google Scholar]
  12. Goldberg L. I., Glock D., Kohli J. D., Barnett A. Separation of peripheral dopamine receptors by a selective DA1 antagonist, SCH 23390. Hypertension. 1984 Mar-Apr;6(2 Pt 2):I25–I30. doi: 10.1161/01.hyp.6.2_pt_2.i25. [DOI] [PubMed] [Google Scholar]
  13. HARVEY R. B., BROTHERS A. J. Renal extraction of para-aminohippurate and creatinine measured by continuous in vivo sampling of arterial and renal-vein blood. Ann N Y Acad Sci. 1962 Oct 31;102:46–54. doi: 10.1111/j.1749-6632.1962.tb13624.x. [DOI] [PubMed] [Google Scholar]
  14. Haber E., Koerner T., Page L. B., Kliman B., Purnode A. Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects. J Clin Endocrinol Metab. 1969 Oct;29(10):1349–1355. doi: 10.1210/jcem-29-10-1349. [DOI] [PubMed] [Google Scholar]
  15. Hagege J., Richet G. Proximal tubule dopamine histofluorescence in renal slices incubated with L-dopa. Kidney Int. 1985 Jan;27(1):3–8. doi: 10.1038/ki.1985.2. [DOI] [PubMed] [Google Scholar]
  16. Horn P. T., Kohli J. D., Goldberg L. I. Effects of dopamine, N-N-di-n-propyl dopamine, and (R)- and (S)-sulpiride on guinea pig blood pressure. J Cardiovasc Pharmacol. 1982 Jul-Aug;4(4):668–675. doi: 10.1097/00005344-198207000-00020. [DOI] [PubMed] [Google Scholar]
  17. Hwang P., Robertson M., Guyda H., Friesen H. The purification of human prolactin from frozen pituitary glands. J Clin Endocrinol Metab. 1973 Jun;36(6):1110–1118. doi: 10.1210/jcem-36-6-1110. [DOI] [PubMed] [Google Scholar]
  18. Israel R., O'Mara V., Austin B., Bellucci A., Meyer B. R. Metoclopramide decreases renal plasma flow. Clin Pharmacol Ther. 1986 Mar;39(3):261–264. doi: 10.1038/clpt.1986.36. [DOI] [PubMed] [Google Scholar]
  19. Jeffrey R. F., MacDonald T. M., Marwick K., Lee M. R. The effect of carbidopa and indomethacin on the renal response to gamma-L-glutamyl-L-dopa in normal man. Br J Clin Pharmacol. 1988 Feb;25(2):195–201. doi: 10.1111/j.1365-2125.1988.tb03291.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Kohli J. D., Cripe L. D. Sulpiride: a weak antagonist of norepinephrine and 5-hydroxytryptamine. Eur J Pharmacol. 1979 Jun 15;56(3):283–286. doi: 10.1016/0014-2999(79)90185-7. [DOI] [PubMed] [Google Scholar]
  21. MacLeod R. M., Robyn C. Mechanism of increased prolactin secretion by sulpiride. J Endocrinol. 1977 Mar;72(3):273–277. doi: 10.1677/joe.0.0720273. [DOI] [PubMed] [Google Scholar]
  22. Nicolas P., Fauvelle F., Ennachachibi A., Merdjan H., Petitjean O. Improved determination of sulpiride in plasma by ion-pair liquid chromatography with fluorescence detection. J Chromatogr. 1986 Sep 5;381(2):393–400. doi: 10.1016/s0378-4347(00)83605-1. [DOI] [PubMed] [Google Scholar]
  23. Shepperson N. B., Duval N., Massingham R., Langer S. Z. Differential blocking effects of several dopamine receptor antagonists for peripheral pre- and postsynaptic dopamine receptors in the anesthetized dog. J Pharmacol Exp Ther. 1982 Jun;221(3):753–761. [PubMed] [Google Scholar]
  24. Spedding M., Berg C. Stereospecific blockade of alpha 2-adrenoceptors by (+)-butaclamol: implications for the characterization of dopamine receptors. J Pharm Pharmacol. 1982 Jan;34(1):56–58. doi: 10.1111/j.2042-7158.1982.tb04681.x. [DOI] [PubMed] [Google Scholar]
  25. Wilk S., Mizoguchi H., Orlowski M. gamma-Glutamyl dopa: a kidney-specific dopamine precursor. J Pharmacol Exp Ther. 1978 Jul;206(1):227–232. [PubMed] [Google Scholar]
  26. Worth D. P., Harvey J. N., Brown J., Worral A., Lee M. R. Domperidone treatment in man inhibits the fall in plasma renin activity induced by intravenous gamma-L-glutamyl-L-dopa. Br J Clin Pharmacol. 1986 May;21(5):497–502. doi: 10.1111/j.1365-2125.1986.tb02831.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES